Cannabis Law Report

DECEMBER 15, 2021

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. ROLE/RESPONSIBILITIES. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Competitive benefit package includes : Paid Time Off (PTO). European Regulatory Lead Executive Summary. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Prior experience as a regional regulatory lead, ideally US and/or UK/EU in pharmaceutical industry. Key Responsibilities.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

JUNE 15, 2022

ZenPharm, ASG Pharma and Panaxia Pharmaceutical MPXI are already licensed for their business in Malta. Clinical trials, etc. Malta is an ideal testbed for research given its small size and business-friendly approach. Malta Enterprise also supports human resources training.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

Cannabis Law Report

OCTOBER 10, 2021

As a senior manager at Cantourage and with us as a team you can develop and shape the pharmaceuticals market in Europe. Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). Customized compensation package.

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

Cannabis Law Report

DECEMBER 18, 2019

…MGC Pharmaceuticals has achieved yet another significant milestone with the bio-pharma company this week surpassing more than 1,800 prescribed products of its medicinal cannabis-based pharmaceutical products in Australia, UK, Brazil and Ireland. The West Australian reports. Source: [link].

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

APRIL 21, 2022

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. Experience in healthcare, mental health, or pharmaceutical/biotech industry required. Competitive benefit package includes.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. A minimum of 5-7 years of legal experience in healthcare or pharmaceutical-related fields. Deputy General Counsel Executive Summary.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

SEPTEMBER 14, 2021

Step three: Radicle Science conducts a rigorous randomized controlled trial of the various formulations to reveal differential effects of various ingredients, combinations of ingredients, dosages and delivery methods on various health-related need states. Step five: The OBX and Radicle Science validated product is sent to production.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

SEPTEMBER 3, 2019

We are delighted to start working with this Licensed Producer, and others, who share our vision of providing the highest quality pharmaceutical-grade products. This input supply will support the extraction and production of private label oil in Australia for local and international markets.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

SEPTEMBER 8, 2021

The Company provides proprietary cannabis processing services, in addition to best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods. About Epsilon Healthcare Limited Epsilon Healthcare (ASX:EPN) is an ASX listed diversified global healthcare and pharmaceuticals company.

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. We are looking forward to the completion of the required IND enabling studies and submitting our IND package to the FDA in anticipation of first-in-human trials,” continued Mr. Mack. About Virpax Pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

JANUARY 9, 2019

Armed with their mission, in June 2018, Phoenix merged many of its partnership organisations together under the name Phoenix Life Sciences International Limited, placing expert botanists, biologists, industrial and organic chemists, medical doctors, researchers, packagers and distributors together under one roof.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

NOVEMBER 10, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Once completed, it is our intention to immediately submit our IND package to the FDA so that we may begin human trials,” commented Virpax’s Chairman & CEO Anthony P. About Virpax Pharmaceuticals. Forward-Looking Statement.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

FEBRUARY 3, 2022

Together with its wide network of research partners, MediCane is executing clinical programs to develop cannabis-based drugs with two leading therapeutic areas – Behavioral and Psychological Symptoms of Dementia (BPSD) and sleep disorders.

Clinical Trials 52

Clinical Trials Research and Development Packaging Oil 52

Cannabis Law Report

SEPTEMBER 21, 2021

Do you think there should be a distinction between pharmaceutical cannabis companies vs cannabis grown for adult use retail? . Yes, pharmaceutical and adult-use retail cannabis are two completely different markets and user groups.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

DECEMBER 20, 2021

The clinical trials shall be conducted to comply with Rule 158(B) of the Drugs and Cosmetics Rules. The clinical trials must be conducted in accordance with the guidelines laid down by the Indian Council of Medical Research.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Cannabis Law Report

MARCH 29, 2020

The guidelines below detail some prime facets to consider in order to maintain high quality control standards in the cannabis research space: o Compliance with the Cannabis Act and the MRIA Code of Conduct including referencing the guidelines listed in the Pharmaceutical Research section.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

The Cannigma

FEBRUARY 11, 2021

All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I So I had been on over 26 pharmaceuticals, including fentanyl, um, and, you name it. You know, started doing clinical trials through Zelda Therapeutics, and all the other things I’ve done.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. listed common and severe side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

The Cannigma

DECEMBER 22, 2021

We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. Well, I think that we can build a wonderful booming adult use consumer packaged goods market. We have, I think, eight PhDs. We have an excellent set of in-house laboratories.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

OCTOBER 17, 2019

Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state. Some of the regulatory controls include limits on THC, packaging and labeling requirements, and products that cannot be combined with THC (e.g., Colorado has legalized both recreational and medical use of cannabis.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

SEPTEMBER 20, 2019

Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. Can you explain how it’s prepared for shipping at the University of Mississippi and how it comes packaged? “It needs FDA approval.”

DEA 228

DEA Research and Development Clinical Trials Patients 228

Cannabis Law Report

DECEMBER 30, 2019

For the first time, the FY 2020 Appropriations package contained this protection for 47 states within the base language of the text. Included in the final FY 2020 spending package). A Pathway Towards SAFE Banking. The House FY 2020 Appropriations bill marks the first time that this language has not been included. California.

Legislation 59

Legislation Patients Access Banking 59